Identification and significance of Streptococcus agalactiae (Lancefield group B).
D000328:Adult; D000941:Antigens; D001414:Bacitracin / Q000494:pharmacology; D002584:Cervix Uteri / Q000382:microbiology; D004423:Ear / Q000382:microbiology; D005260:Female; D005455:Fluorescent Antibody Technique; D005831:Genital Diseases, Female / Q000382:microbiology; D005836:Genitalia, Female / Q000382:microbiology; D006626:Hippurates / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000382:microbiology*; D007501:Iron / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D010614:Pharynx / Q000382:microbiology; D010920:Placenta / Q000382:microbiology; D012141:Respiratory Tract Infections / Q000382:microbiology; D012867:Skin / Q000382:microbiology; D013290:Streptococcal Infections / Q000188:drug therapy / Q000382:microbiology*; D013291:Streptococcus / Q000187:drug effects / Q000254:growth & development / Q000276:immunology / Q000302:isolation & purification*; D014470:Umbilical Cord / Q000382:microbiology; D014552:Urinary Tract Infections / Q000382:microbiology*; D014621:Vagina / Q000382:microbiology
D000941:Antigens; D006626:Hippurates; D010406:Penicillins; D001414:Bacitracin; D007501:Iron